These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21801150)

  • 1. Anti-breast cancer agents, quinolines, targeting gap junction.
    Bernzweig J; Heiniger B; Prasain K; Lu J; Hua DH; Nguyen TA
    Med Chem; 2011 Sep; 7(5):448-53. PubMed ID: 21801150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.
    Gakhar G; Hua DH; Nguyen TA
    Anticancer Drugs; 2010 Jan; 21(1):77-88. PubMed ID: 19966541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the PQ1 anti-breast cancer agent on normal tissues.
    Ding Y; Prasain K; Nguyen TD; Hua DH; Nguyen TA
    Anticancer Drugs; 2012 Oct; 23(9):897-905. PubMed ID: 22569107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation substituted quinolines as anticancer drugs for breast cancer.
    Heiniger B; Gakhar G; Prasain K; Hua DH; Nguyen TA
    Anticancer Res; 2010 Oct; 30(10):3927-32. PubMed ID: 21036704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
    Thigulla Y; Akula M; Trivedi P; Ghosh B; Jha M; Bhattacharya A
    Org Biomol Chem; 2016 Jan; 14(3):876-83. PubMed ID: 26592542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
    Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
    Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
    Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, crystal structures and anticancer activity of 4-substituted quinolines to target PDK1.
    Vennila KN; Sunny D; Madhuri S; Ciattini S; Chelazzi L; Elango KP
    Bioorg Chem; 2018 Dec; 81():184-190. PubMed ID: 30138906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational treatment of gap junction enhancers and paclitaxel attenuates mammary tumor growth.
    Shishido S; Nguyen TA
    Anticancer Drugs; 2020 Apr; 31(4):353-358. PubMed ID: 31913199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach.
    Viswas RS; Pundir S; Lee H
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):620-630. PubMed ID: 30727782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis.
    Chang WT; Fong Y; Chuang SC; Chou CK; Chou HL; Yang CF; Tseng CH; Chen YL; Chiu CC
    Anticancer Agents Med Chem; 2017; 17(5):692-700. PubMed ID: 27491935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gap junction enhancer increases efficacy of cisplatin to attenuate mammary tumor growth.
    Shishido SN; Nguyen TA
    PLoS One; 2012; 7(9):e44963. PubMed ID: 23028705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-breast cancer activities of substituted quinolines.
    Shi A; Nguyen TA; Battina SK; Rana S; Takemoto DJ; Chiang PK; Hua DH
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3364-8. PubMed ID: 18457950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 3-aryl-quinolin derivatives as anti-breast cancer agents targeting ERα and VEGFR-2.
    Li X; Wu C; Lin X; Cai X; Liu L; Luo G; You Q; Xiang H
    Eur J Med Chem; 2019 Jan; 161():445-455. PubMed ID: 30384047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential.
    Costa CA; Lopes RM; Ferraz LS; Esteves GNN; Di Iorio JF; Souza AA; de Oliveira IM; Manarin F; Judice WAS; Stefani HA; Rodrigues T
    Bioorg Med Chem; 2020 Jun; 28(11):115511. PubMed ID: 32336669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new steroidal quinolines with antitumor properties.
    Yang YT; Du S; Wang S; Jia X; Wang X; Zhang X
    Steroids; 2019 Nov; 151():108465. PubMed ID: 31351940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells.
    Cos S; Fernández R
    J Pineal Res; 2000 Oct; 29(3):166-71. PubMed ID: 11034114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines.
    Gopaul K; Shintre SA; Koorbanally NA
    Anticancer Agents Med Chem; 2015; 15(5):631-46. PubMed ID: 25511516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-catalyzed direct C-H thiolation of imidazo[1,5-a]quinolines for the synthesis of 3-sulfenylimidazo[1,5-a]quinolines.
    Wu SS; Feng CT; Hu D; Huang YK; Li Z; Luo ZG; Ma ST
    Org Biomol Chem; 2017 Feb; 15(7):1680-1685. PubMed ID: 28134380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
    Fernández-Sáez N; Rubio-Ruiz B; Campos JM; Unciti-Broceta A; Carrión MD; Camacho ME
    Future Med Chem; 2019 Jan; 11(2):83-95. PubMed ID: 30644318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.